The manufacturer —which recently left Massachusetts for New Hampshire — will absorb 1,500 employees in the deals.

The combined company will operate as Obsidian Therapeutics following the merger. Investors in the $350 million private ...

Gay Treasury Secretary Scott Bessent recently issued a rambling and scientifically incoherent response when asked about ...